About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide
By
Juan Frias
2 Videos
9,581 views
April 11, 2022
7 Comments
Login to view comments.
Click here to Login
Featured Video
18:06
Lilly Obesity
Getting Patients Started with an Obesity Treatment Option for Adults
Feat.
E. Lazarus
Featured Video
18:06
Lilly Obesity
Getting Patients Started with an Obesity Treatment Option for Adults
Feat.
E. Lazarus
Related Content
AUTOPLAY
ON
47:11
Houston Methodist Hospital
The Protein Myth: Our Obsession With Protein and How It Is Killing US
Feat.
G. Davis
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
49:21
Physicians Committee for Responsible Medicine
Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…
Feat.
T. J. Key
34:49
Scripps Health
Medications for Weight Loss: The New Satiety Hormones
Feat.
K. Fujioka
23:35
Practical Ways to Achieve Targets in Diabetes Care
Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)
Feat.
I. Hirsch
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
15:06
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
37:21
University of Colorado Department of Medicine
Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…
Feat.
R. Johnson
15:33
Ken Fujioka
Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…
17:44
Rita Jermyn
SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
26:32
Practical Ways to Achieve Targets in Diabetes Care
Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity
Feat.
S. Nissen
20:24
Diana Isaacs
Tirzepatide for Type 2 Diabetes
44:41
Norman Lepor
Obesity: New Understanding and Treatments
26:49
Diana Isaacs
Tirzepatide Updates
44:43
Jason Fung
Type 2 Diabetes Aetiology and Reversibility
05:08
Susan Brian
The Differences Between the Products of GLP1's and GLP/GIPs
23:21
Practical Ways to Achieve Targets in Diabetes Care
TIR vs. A1c: Q&A/ Panel Discussion
Feat.
J. Skyler,
G. Aleppo,
T. Danne,
L. Barbour
06:31
Susan Brian
Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist
05:40
Susan Brian
An Introduction to Tirzepatide for Weightloss